Tradercommunity Clickoptions Forum

[Newsagent]

PR inside: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of ...

(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / July 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ:CAPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether Capricor and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

May 5, 2025, Capricor issued a press release announcing that after "the completion of a mid-cycle review meeting with the U.S. Food and Drug Administration (FDA) for the ..

https://reports.pr-inside.com/investor- ... 120948.htm
Copyright PR-Inside.com 2025